Ana Gorostidi

3.1k total citations
30 papers, 891 citations indexed

About

Ana Gorostidi is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Ana Gorostidi has authored 30 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 11 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Ana Gorostidi's work include Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological diseases and metabolism (7 papers) and Alzheimer's disease research and treatments (5 papers). Ana Gorostidi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological diseases and metabolism (7 papers) and Alzheimer's disease research and treatments (5 papers). Ana Gorostidi collaborates with scholars based in Spain, United States and Cuba. Ana Gorostidi's co-authors include Adolfo López de Munaín, Javier Ruiz‐Martínez, J.F. Martí-Massó, Alberto Bergareche, Ainhoa Alzualde, Rosario Sánchez‐Pernaute, Fermín Moreno, Rakel López de Maturana, Ana Aiastui and Coro Paisán‐Ruiz and has published in prestigious journals such as PLoS ONE, Genetics and Human Molecular Genetics.

In The Last Decade

Ana Gorostidi

30 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Gorostidi Spain 20 607 303 228 224 204 30 891
Kateřina Venderová United States 13 574 0.9× 438 1.4× 227 1.0× 172 0.8× 436 2.1× 17 1.2k
Krisztina K. Johansen Norway 16 703 1.2× 247 0.8× 301 1.3× 194 0.9× 238 1.2× 24 933
Kaisa M.A. Kurkinen Finland 14 415 0.7× 452 1.5× 358 1.6× 191 0.9× 277 1.4× 19 975
Etsuro Ohta Japan 14 591 1.0× 324 1.1× 251 1.1× 199 0.9× 197 1.0× 23 764
Eleanna Kara United Kingdom 17 729 1.2× 322 1.1× 352 1.5× 259 1.2× 406 2.0× 25 1.1k
Andrew Ferree United States 15 400 0.7× 579 1.9× 219 1.0× 188 0.8× 354 1.7× 20 1.1k
Linan Chen China 8 624 1.0× 479 1.6× 228 1.0× 169 0.8× 416 2.0× 18 1.1k
Jonathan C. Grima United States 10 406 0.7× 517 1.7× 178 0.8× 108 0.5× 186 0.9× 10 903
Amanda Singleton United States 14 666 1.1× 290 1.0× 202 0.9× 170 0.8× 490 2.4× 17 985
Lasse Pihlstrøm Norway 18 549 0.9× 310 1.0× 222 1.0× 229 1.0× 284 1.4× 49 904

Countries citing papers authored by Ana Gorostidi

Since Specialization
Citations

This map shows the geographic impact of Ana Gorostidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Gorostidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Gorostidi more than expected).

Fields of papers citing papers by Ana Gorostidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Gorostidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Gorostidi. The network helps show where Ana Gorostidi may publish in the future.

Co-authorship network of co-authors of Ana Gorostidi

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Gorostidi. A scholar is included among the top collaborators of Ana Gorostidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Gorostidi. Ana Gorostidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riva, Patricia de la, J. Muñoz, V. Gómez, et al.. (2022). Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy. Nitric Oxide. 129. 8–15. 2 indexed citations
2.
Vinagre‐Aragón, Ana, et al.. (2021). A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene. Frontiers in Neurology. 12. 635396–635396. 13 indexed citations
3.
Moreno, Fermín, Begoña Indakoetxea, Myriam Barandiarán, et al.. (2017). The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics. PLoS ONE. 12(6). e0178093–e0178093. 4 indexed citations
4.
Maturana, Rakel López de, Valerie J. Lang, Ana Gorostidi, et al.. (2016). Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons. Journal of Neuroinflammation. 13(1). 295–295. 54 indexed citations
5.
Gorostidi, Ana, J.F. Martí-Massó, Alberto Bergareche, et al.. (2016). Genetic Mutation Analysis of Parkinson’s Disease Patients Using Multigene Next-Generation Sequencing Panels. Molecular Diagnosis & Therapy. 20(5). 481–491. 11 indexed citations
6.
Bergareche, Alberto, Elena Sánchez, Catharine E. Krebs, et al.. (2015). SCN4Apore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy. Human Molecular Genetics. 24(24). ddv410–ddv410. 32 indexed citations
7.
Ruiz‐Martínez, Javier, Catharine E. Krebs, Vladimir Makarov, et al.. (2015). GIGYF2 mutation in late-onset Parkinson’s disease with cognitive impairment. Journal of Human Genetics. 60(10). 637–640. 16 indexed citations
8.
Alvarez‐Castelao, Beatriz, et al.. (2014). Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls. Frontiers in Aging Neuroscience. 6. 169–169. 9 indexed citations
9.
Estanga, Ainara, María Rodríguez‐Oroz, Javier Ruiz‐Martínez, et al.. (2014). Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2. Parkinsonism & Related Disorders. 20(10). 1097–1100. 15 indexed citations
10.
Aramburu, Isabel González, Pascual Sánchez‐Juan, Silvia Jesús, et al.. (2013). Genetic variability related to serum uric acid concentration and risk of Parkinson's disease. Movement Disorders. 28(12). 1737–1740. 38 indexed citations
11.
Maturana, Rakel López de, et al.. (2013). Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease. Neurobiology of Aging. 35(5). 1116–1124. 30 indexed citations
12.
Pedro, José Manuel Bravo‐San, Rubén Gómez‐Sánchez, Mireia Niso‐Santano, et al.. (2012). The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts. Autophagy. 8(10). 1537–1539. 22 indexed citations
13.
Pedro, José Manuel Bravo‐San, Mireia Niso‐Santano, Rubén Gómez‐Sánchez, et al.. (2012). The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cellular and Molecular Life Sciences. 70(1). 121–136. 129 indexed citations
14.
Gorostidi, Ana, Alberto Bergareche, Javier Ruiz‐Martínez, et al.. (2012). α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers. PLoS ONE. 7(12). e52312–e52312. 38 indexed citations
15.
Ruiz‐Martínez, Javier, Ana Gorostidi, Estíbaliz Goyenechea, et al.. (2011). Olfactory deficits and cardiac 123I‐MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations. Movement Disorders. 26(11). 2026–2031. 44 indexed citations
16.
Ruiz-Martı́nez, Javier, Ana Gorostidi, Berta Ibáñez, et al.. (2010). Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain). Movement Disorders. 25(14). 2340–2345. 42 indexed citations
17.
Alzualde, Ainhoa, Fermín Moreno, Pablo Martínez‐Lage, et al.. (2010). Somatic mosaicism in a case of apparently sporadic Creutzfeldt‐Jakob disease carrying a de novo D178N mutation in the PRNP gene. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(7). 1283–1291. 26 indexed citations
18.
Alzualde, Ainhoa, Begoña Indakoetxea, Isidró Ferrer, et al.. (2010). A NovelPRNP Y218NMutation in Gerstmann-Sträussler-Scheinker Disease With Neurofibrillary Degeneration. Journal of Neuropathology & Experimental Neurology. 69(8). 789–800. 37 indexed citations
19.
Martí-Massó, J.F., Javier Ruiz‐Martínez, Irune Ruiz, et al.. (2009). Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Movement Disorders. 24(13). 1998–2001. 57 indexed citations
20.
Gorostidi, Ana, Javier Ruiz‐Martínez, Adolfo López de Munaín, Ainhoa Alzualde, & J.F. Martí-Massó. (2008). LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicity. Neurogenetics. 10(2). 157–159. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kateřina Venderová Breakdown of academic impact, for papers by Krisztina K. Johansen Breakdown of academic impact, for papers by Kaisa M.A. Kurkinen Breakdown of academic impact, for papers by Etsuro Ohta Breakdown of academic impact, for papers by Eleanna Kara Breakdown of academic impact, for papers by Andrew Ferree Breakdown of academic impact, for papers by Linan Chen Breakdown of academic impact, for papers by Jonathan C. Grima Breakdown of academic impact, for papers by Amanda Singleton Breakdown of academic impact, for papers by Lasse Pihlstrøm
Rankless by CCL
2026